What Is Eylea?
Eylea is a drug synthesized from a human antibody fragment. Its primary purpose is to prevent the formation of new blood vessels beneath the retina (a sensitive lining that surrounds the interior portions of the eye). Formation of new blood vessels under the eyes occurs in certain eye conditions. In some cases, leakage of fluid and blood may occur. This condition is clinically referred to as the “wet form” of macular degeneration.
What Are the Uses of Eylea?
- Eylea is used to treat age-induced macular degeneration.
- It helps reduce swelling in the retina caused by formation of new blood vessels.
- Eylea can also be used to treat diabetic retinopathy, an eye condition caused by diabetics which causes accumulation of fluid in the retina and can lead to blindness.
Doctors advise people who are allergic to aflibercept to avoid using Eylea. It can also worsen infections (viral, fungal, and bacterial) in the eye, or swelling inside the eyes. Speak with your doctor immediately if you notice any signs of redness, eye pain, puffiness around the eyes, swelling, or unusual vision disorders during treatment.